Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Journal of the Advanced Practitioner in Oncology
|
December 5, 2025
The Factor Approach: Coagulation Treatment Optimization and Recommendations (FACTOR)
Sara Leidy, Zahra Mahmoudjafari
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 11, 2022
Expanding oncology pharmacist teams: Justifying the return on investment
Zahra Mahmoudjafari, Shannon Hough
Transplantation and Cellular Therapy
|
January 18, 2026
G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant?
Nausheen Ahmed, Zahra Mahmoudjafari
Transplantation and Cellular Therapy
|
January 9, 2026
From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs
Zahra Mahmoudjafari, Joseph McGuirk, Nausheen Ahmed
Transplantation and Cellular Therapy
|
March 29, 2023
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy
Nausheen Ahmed, Zahra Mahmoudjafari, Mehdi Hamadani, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 8, 2025
Stay, stay, stay (our version): The value of staying power in navigating the challenges and changes of a career in clinical pharmacy
Kamakshi V Rao, Zahra Mahmoudjafari, Alison M Gulbis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2023
Financial Toxicity in Oncology, More Unanswered Questions
Ryan J Beechinor, Zahra Mahmoudjafari, Ghulam Rehman Mohyuddin
Clinical Hematology International
|
May 31, 2024
Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy
Nausheen Ahmed, Olalekan Oluwole, Zahra Mahmoudjafari, et al.
Therapeutic Advances in Hematology
|
May 25, 2026
Clinical considerations for ruxolitinib in the treatment of steroid-refractory acute graft-versus-host disease (GVHD) and steroid-refractory or -dependent chronic GVHD: a plain language summary
Zahra Mahmoudjafari, Valkal Bhatt, Zhenyi Xue, et al.
Leukemia & Lymphoma
|
April 9, 2025
Glofitamab results in cost savings versus epcoritamab in relapsed/refractory diffuse large B-cell lymphoma: a total cost of care analysis<sup>‡</sup>
Zahra Mahmoudjafari, Danilo Di Maio, Jia Li, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Journal of the Advanced Practitioner in Oncology
|
December 5, 2025
The Factor Approach: Coagulation Treatment Optimization and Recommendations (FACTOR)
Sara Leidy, Zahra Mahmoudjafari
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 11, 2022
Expanding oncology pharmacist teams: Justifying the return on investment
Zahra Mahmoudjafari, Shannon Hough
Transplantation and Cellular Therapy
|
January 18, 2026
G-CSF Timing After CAR-T: Early, Late - or Just Irrelevant?
Nausheen Ahmed, Zahra Mahmoudjafari
Transplantation and Cellular Therapy
|
January 9, 2026
From Vision to Viability: Developing Infrastructure for Cell and Gene Therapy Programs
Zahra Mahmoudjafari, Joseph McGuirk, Nausheen Ahmed
Transplantation and Cellular Therapy
|
March 29, 2023
Bridging the Gap: Early Transition and Hybrid Models of Care to Improve Access to Chimeric Antigen Receptor T Cell Therapy
Nausheen Ahmed, Zahra Mahmoudjafari, Mehdi Hamadani, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 8, 2025
Stay, stay, stay (our version): The value of staying power in navigating the challenges and changes of a career in clinical pharmacy
Kamakshi V Rao, Zahra Mahmoudjafari, Alison M Gulbis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 2023
Financial Toxicity in Oncology, More Unanswered Questions
Ryan J Beechinor, Zahra Mahmoudjafari, Ghulam Rehman Mohyuddin
Clinical Hematology International
|
May 31, 2024
Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy
Nausheen Ahmed, Olalekan Oluwole, Zahra Mahmoudjafari, et al.
Therapeutic Advances in Hematology
|
May 25, 2026
Clinical considerations for ruxolitinib in the treatment of steroid-refractory acute graft-versus-host disease (GVHD) and steroid-refractory or -dependent chronic GVHD: a plain language summary
Zahra Mahmoudjafari, Valkal Bhatt, Zhenyi Xue, et al.
Leukemia & Lymphoma
|
April 9, 2025
Glofitamab results in cost savings versus epcoritamab in relapsed/refractory diffuse large B-cell lymphoma: a total cost of care analysis<sup>‡</sup>
Zahra Mahmoudjafari, Danilo Di Maio, Jia Li, et al.
Page
of 7